LC
BLUE

Lindbrook Capital’s bluebird bio BLUE Stock Holding History

Lindbrook Capital’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-32
Closed -$896 – 2658
2023
Q4 		$896 Buy
32
+24
+300% +$1.46K ﹤0.01% 2493
2023
Q3 		$496 Sell
8
-7
-47% -$492 ﹤0.01% 2542
2023
Q2 		$967 Buy
15
+11
+275% +$805 ﹤0.01% 2374
2023
Q1 		$251 Sell
4
-37
-90% -$4.22K ﹤0.01% 2696
2022
Q4 		$5.66K Buy
41
+26
+173% +$3.66K ﹤0.01% 1754
2022
Q3 		$2K Buy
15
+13
+650% +$1.47K ﹤0.01% 2000
2022
Q2 		$0 Sell
2
-9
-82% -$698 ﹤0.01% 2502
2022
Q1 		$1K Buy
11
+4
+57% +$528 ﹤0.01% 2177
2021
Q4 		$1K Sell
7
-3
-30% -$708 ﹤0.01% 1882
2021
Q3 		$3K Buy
+10
New +$2.86K ﹤0.01% 1380
2021
Q2 		– Sell
-4
Closed -$2K – 1915
2021
Q1 		$2K Sell
4
-3
-43% -$1.48K ﹤0.01% 1520
2020
Q4 		$4K Buy
+7
New +$4.44K ﹤0.01% 1235
2020
Q3 		– Sell
-1
Closed -$1K – 1747
2020
Q2 		$1K Buy
+1
New +$754 ﹤0.01% 1518

Other funds holding BLUE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Lindbrook Capital's BLUE Position: Q1 2024 in Review

Lindbrook Capital sold out of bluebird bio (BLUE) in Q1 2024, closing a stake of 32 shares — an estimated $896 sold.

Lindbrook Capital first reported a position in BLUE in Q2 2020 and held it in 13 quarters. The position peaked at $5.66K in Q4 2022. 158 funds tracked by Wall St. Rank hold BLUE as of Q1 2024.

  • Lindbrook Capital reported no remaining bluebird bio position as of Q1 2024 after selling out during the quarter.
  • Lindbrook Capital sold 32 bluebird bio shares in Q1 2024, an estimated $896.
  • Lindbrook Capital first reported a position in bluebird bio in Q2 2020 and held it in 13 quarters.
  • Lindbrook Capital's bluebird bio position peaked at $5.66K in Q4 2022.
  • 158 funds tracked by Wall St. Rank held bluebird bio as of Q1 2024.

Based on Lindbrook Capital's 13F filing for Q1 2024, filed 25 Apr 2024.